Willkie Advises Auxilium in $657 Million Acquisition of Actient

On April 29, it was announced that Willkie client Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, has completed its acquisition of private urology specialty therapeutics company Actient Holdings LLC. Auxilium is paying $585 million in upfront cash plus certain contingent consideration and warrants to purchase Auxilium common stock, for a total enterprise value of up to $657 million. Based in Lake Forest, IL, Actient’s urology portfolio includes TESTOPEL, the only long-acting implantable testosterone replacement therapy (TRT) and Edex, the leading branded non-oral drug for erectile dysfunction. Chesterbrook, PA-based Auxilium focuses on developing and marketing products, including Testim 1% (testosterone gel) in the U.S. for the topical treatment of hypogonadism, to predominantly specialist audiences. The deal is expected to create a leading urology platform with the widest range of products for TRT.

More >>

Tags:  Willkie Farr & Gallagher LLP | New York

Simpson Thacher Represents the Stephen A. Schwarzman Education Foundation in Connection with $300 Million Scholarship Fund for Study at Tsinghua University

The Firm represented the Stephen A. Schwarzman Education Foundation in connection with the creation of a $300 million scholarship fund for study at Tsinghua University in Beijing and the creation of Schwarzman College at the University. The program, whose endowment represents one of the largest single gifts to education in the world and one of the largest philanthropic gifts ever in China, was announced by Mr. Schwarzman in Beijing on Sunday. The gift, also announced on “Face the Nation,” was the subject of an article in Sunday’s New York Times and was the national headline news in the prime-time news programs by all Chinese state-run TV stations.

More >>

Tags:  Simpson Thacher & Bartlett LLP | Beijing

Simpson Thacher Represents Underwriters in $2.3 Billion Initial Public Offering of DoubleLine Income Solutions Fund

Simpson Thacher recently represented a group of underwriters in connection with the initial public offering of DoubleLine Income Solutions Fund (the “Fund”). The offering raised $2.3 billion and represents one of the largest IPOs for any closed-end bond fund in the U.S. The Fund is a newly organized, non-diversified, closed-end management investment company which trades on the New York Stock Exchange under the symbol “DSL”. The lead underwriters in the transaction were UBS Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Citigroup Global Markets Inc., Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York